About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in Massachusetts | 439 Studies

Clinical Trials Ovarian CancerMassachusetts

Ovarian Cancer Clinical Trials in Massachusetts

Find 439 clinical trials for ovarian cancer near Massachusetts. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 141-160 of 439 trials

CompletedStudy to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerThe purpose of the study is to see if the drug KU 0059436 is effective and well tolerated in treating patients with measurable BRCA1- or BRCA2-positive advanced ovarian cancer and…NCT00494442·Los Angeles, California and 10 others TerminatedVeliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerThe primary objective of the study was to evaluate whether progression-free survival (PFS) was prolonged with the addition of veliparib to standard platinum-based chemotherapy…NCT02470585·Birmingham, Alabama and 209 others

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor) monotherapy in adult…NCT05462717·Springdale, Arkansas and 63 others

Active not recruitingAscending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer AgentsThis is a modular, phase I/ phase 1 b, open-label, multicentre study of ceralasertib administered orally in combination with cytotoxic chemotherapy regimens and/or novel…NCT02264678·Duarte, California and 27 others

CompletedIressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian CancerThe main purpose of this study is to determine the effects (good and bad) Iressa plus anastrozole has on patients with relapsed ovarian cancer.NCT00181688·Boston, Massachusetts and 1 other

CompletedA Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung CancerThis open-label, multicenter, phase 1b study will evaluate the safety and pharmacokinetics of DNIB0600A in participants with platinum-sensitive ovarian cancer (PSOC) or…NCT01995188·Boston, Massachusetts and 3 others

UnknownChemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerThis trial studies the chemotherapy toxicity on quality of life in older patients with stage I, stage II, stage III, or stage IV ovarian epithelial, primary peritoneal cavity, or…NCT01366183·Birmingham, Alabama and 356 others

CompletedNirogacestat in Ovarian Granulosa Cell TumorsThis phase 2 clinical trial will study the effectiveness of nirogacestat in ovarian granulosa cell tumors (OvGCTs).NCT05348356·Los Angeles, California and 20 others

CompletedQuality of Life in Survivors of Gynecologic CancerRATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term effects of having had gynecologic cancer and may help improve the quality of life for…NCT00003795·Birmingham, Alabama and 43 others

CompletedStudy With Afuresertib and Paclitaxel in Platinum Resistant OvarianAfuresertib is an AKT inhibitor, a new class of agents under development that may provide physicians with a new clinical option to control platinum resistant ovarian cancer (PROC)…NCT04374630·Phoenix, Arizona and 46 others

UnknownA Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsThis is a phase 1, Open-label, multicenter Dose Escalation study of BTP-114, a novel platinum product, in patients with advanced solid tumors and BRCA or other DNA repair mutation.NCT02950064·Sarasota, Florida and 7 others

UnknownMonoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and ChemotherapyRATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00003634·Berkeley, California and 45 others

CompletedPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase II trial is studying the side effects and how well paclitaxel albumin-stabilized nanoparticle formulation works in treating patients with recurrent or persistent…NCT00499252·Aurora, Colorado and 19 others

SuspendedA Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid TumorThis is an open-label, Phase 1b/2 study to determine the recommended dose of lucitanib in combination with nivolumab in patients with an advanced solid tumor (Phase 1b); followed…NCT04042116·Los Angeles, California and 26 others

CompletedDocetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer PatientsThe main purpose of this study is to see if the study drug, PTK787, is safe and to find the highest dose that can be given safely without causing serious side effects.NCT00268918·Boston, Massachusetts and 1 other

CompletedEnoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing MicroparticlesResearch studies have shown a strong association between cancer and blood clots in the veins (also known as deep vein thrombosis).NCT00908960·Los Angeles, California and 4 others

CompletedTirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00020696·Birmingham, Alabama and 53 others

CompletedCarboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian CancerThe purpose of this study is to determine the effects (good and bad) the combination of carboplatin and pemetrexed have on patients with recurrent ovarian, peritoneal, or…NCT00230542·Boston, Massachusetts and 2 others

CompletedBevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the OvaryThis phase II trial studies how well bevacizumab works in treating patients with sex cord-stromal tumors of the ovary that have come back.NCT00748657·Los Angeles, California and 35 others

CompletedNivolumab With or Without Ipilimumab in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase II trial studies how well nivolumab works with or without ipilimumab in treating patients with epithelial ovarian, primary peritoneal, or fallopian tube…NCT02498600·Auburn, California and 200 others

PreviousPage 8 of 22Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia